Skip to main content
main-content

Metabolic surgery

News

08-12-2019 | Metabolic surgery | Highlight | News

Bariatric surgery linked to late adverse events

People who undergo bariatric surgery have a lower long-term risk for mortality, but a higher risk for adverse events such as gastrointestinal and nutritional disorders, compared with those who do not undergo surgery, researchers report.

06-06-2019 | Liraglutide (T2DM) | News

Liraglutide may be an option for people with unresolved type 2 diabetes after metabolic surgery

Findings from the GRAVITAS trial indicate that use of the GLP-1 receptor agonist liraglutide alongside a diet and physical activity intervention may improve glycemic control among people with persistent or recurrent type 2 diabetes after bariatric surgery.

03-08-2019 | Obesity | News

Similar weight-loss outcomes with one anastomosis, Roux-en-Y gastric bypass procedures

Findings from the YOMEGA trial indicate that the one anastomosis gastric bypass procedure is noninferior to standard Roux-en-Y gastric bypass in terms of weight loss and metabolic outcomes.

10-29-2018 | Metabolic surgery | News

Effectiveness of bariatric surgery varies across procedures

Patients undergoing Roux-en-Y gastric bypass experience significantly greater weight loss for at least 5 years than those undergoing sleeve gastrectomy and adjustable gastric banding, but are at greater risk for adverse events, research shows.

10-10-2018 | Laparascopic gastric band | EASD 2018 | News

Gastric banding has little effect on beta-cell decline in early type 2 diabetes

The results of the adult surgery study from the RISE consortium show that gastric banding has only a small effect on the deterioration of beta-cell function relative to metformin, despite causing markedly greater weight loss.

08-21-2018 | Metabolic surgery | News

Novel scoring system identifies longer term type 2 diabetes remission after gastric bypass

A novel scoring system that could be used in routine clinical care can predict remission from type 2 diabetes 5 years after gastric bypass surgery, researchers report.

06-24-2018 | Metabolic surgery | ADA 2018 | News

Risks and benefits of gastric bypass surgery shown in obese patients with type 2 diabetes

Gastric bypass surgery benefits obese patients with type 2 diabetes in many ways, but such benefits come at a cost, show data presented at the ADA’s 78th Scientific Sessions in Orlando, Florida.

09-20-2017 | Metabolic surgery | News

Gastric bypass results in ‘near-complete’ long-term diabetes prevention

Research shows that patients who undergo Roux-en-Y gastric bypass are extremely unlikely to develop diabetes over the following decade, and a large proportion of those who have the condition at the time of surgery achieve remission.

08-09-2017 | Metabolic surgery | News

Gastric bypass protects against all-cause death only in patients with diabetes

The all-cause mortality benefits of Roux-en-Y gastric bypass surgery are predominantly driven by patients who have diabetes at the time of surgery, according to the results of an observational study.

07-28-2017 | Metabolic surgery | News

Earlier intervention may boost bariatric surgery effectiveness

A study suggests that obese patients may improve their chances of becoming non-obese and reversing comorbidities such as diabetes if they undergo bariatric surgery before their body mass index reaches 40 kg/m2.

05-19-2017 | Obesity | News

In other news: European Congress on Obesity

The 24th European Congress on Obesity is taking place this week in Porto, Portugal, with key presentations including the findings from the World Health Organization’s Health Behaviour in School-aged Children survey.

03-03-2017 | Metabolic surgery | News

Prediabetics may gain most in long term from bariatric surgery

Research shows that the largest long-term reductions in microvascular complications around 20 years after bariatric surgery for obesity are seen among patients who had prediabetes at the time of surgery.

02-15-2017 | Metabolic surgery | News

Long-term metabolic surgery outcomes durable in STAMPEDE

Long-term follow-up of the STAMPEDE trial shows that improvements in body mass index and glycemic control are maintained 5 years after metabolic surgery in patients with type 2 diabetes.

01-06-2017 | Obesity | News

Promising long-term outcomes after bariatric surgery in adolescence

Two studies of patients who underwent bariatric surgery during adolescence reveal sustained weight loss and improved cardiovascular risk factors 5 years or more after the procedure.

10-20-2016 | Metabolic surgery | News

Closed-loop gastric stimulation on a par with gastric band

Closed-loop gastric electrical stimulation is noninferior to adjustable gastric band for weight loss and has markedly fewer adverse effects, show the 1-year findings of a randomised trial.

Image Credits